HIL Applied Medical Overview

HIL Applied Medical is developing ultra-compact, high-performance accelerators for proton therapy. The company applies a patented, laser-based, nanotech-enabled approach to particle acceleration to facilitate cost-effective, single-room proton therapy systems.

HIL is also developing ultra-compact beam delivery solutions, specifically beamlines and rotating gantries, that take advantage of the unique properties of laser-accelerated proton beams. With this technology, the company can offer further reductions in the size, cost, and complexity of a complete system.

HILs technology aims to enable cost-effective, expandable, add-on single-room solutions while providing clinical capabilities such as 360 rotation, integrated imaging, pencil-beam scanning, IMPT, gating, and adaptive therapy.

The companys technology was conceived and incubated at the high-energy physics lab of the Hebrew University in Jerusalem.

Cumulative Funding Raised Over Time ($)

Employees Over Time

Israeli startup uses Hebrew U breakthrough to cut the cost of treating cancer - Sponsored Content The Times of Israel

#Investment #Partners #Expand

HIL Applied Medical and Proton International Awarded $900K Grant From the BIRD Foundation to Advance An Ultra-Compact, Affordable Proton Beam Therapy Solution for Cancer

#Investment

HIL awarded €2.5M in grant funding by the EU - HIL Applied Medical

#Investment

Cancer Treatment Company HIL to Set Up $5 Million Jerusalem Manufacture Center

#Partners #Expand

HIL is selected as a Silicon70 2018 Company - HIL Applied Medical

#Partners